Contrive Datum Insights_Logo.jpg
In Vitro Cancer Diagnostics Market Is Expected To Grow at a CAGR Of 3.9% during Forecast Period 2023 To 2030 | Data By Contrive Datum Insights Pvt Ltd.
January 13, 2023 13:07 ET | Contrive Datum Insights Pvt Ltd
Farmington, Jan. 13, 2023 (GLOBE NEWSWIRE) -- The Global In-vitro Cancer Diagnostic Market is expected to grow at a CAGR of 3.9% during the forecasting period 2023-2030. Cancer is the growth of...
Medi Tech Insights Logo.jpg
Global Point-of-Care (POC) Blood Diagnostics Market is set to witness a growth rate of 6% by 2026 – Increasing Occurrence of Cardiovascular & Infectious Diseases
August 16, 2022 09:30 ET | Medi-Tech Insights
BRUSSELS, BELGIUM, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Description: Point-of-care (POC) testing entails performing a diagnostic test outside of a laboratory, or near a patient and at the site where...
Global Coagulation Testing Market Anticipated to Garner a Revenue of $3,566.0 Million at a CAGR of 5.9% during the Forecast Period, 2019-2026 - Absolute Report [Pages-105] by Research Dive
June 15, 2021 09:15 ET | Research Dive
New York, USA, June 15, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global coagulation testing market is projected to register a revenue of $3,566.0  million at a...
Emergen logo.png
Patient Registry Software Market Size to Reach USD 2.96 Bn by 2027 | Rising Incidence of Chronic Diseases and Increasing Initiatives Related to Value-Based Care will be the Key Factor Driving the Industry Growth, States Emergen Research
January 26, 2021 14:00 ET | Emergen Research
Vancouver, British Columbia, Jan. 26, 2021 (GLOBE NEWSWIRE) -- The global patient registry software market is forecast to reach a value of USD 2.96 Billion by 2027, at a rapid and steady CAGR of...
OptimizeRx Launches AI-Powered Real-World Evidence Solution on Its Point-of-Care Platform
December 01, 2020 07:31 ET | OptimizeRx Corporation
ROCHESTER, Mich., Dec. 01, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has...
Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test
June 12, 2020 08:00 ET | Cue Health Inc.
SAN DIEGO, June 12, 2020 (GLOBE NEWSWIRE) -- Cue Health Inc. (“Cue”), a healthcare technology company, announced today that it has received Emergency Use Authorization (“EUA”) from the U.S. Food and...
2019_10_18 Sense Logo - 2 colour - RGB - transparent.png
Sense Appoints John Bishop to its Board of Directors
April 21, 2020 02:00 ET | Sense Biodetection
Former Cepheid CEO joins as company launches an accelerated program for the world’s first instrument-free molecular test for COVID-19 CAMBRIDGE and OXFORD, UNITED KINGDOM, April 21, 2020 (GLOBE...
Parallax Announces Immediate Availability Point-of-Care COVID-19 Diagnostic Testing Kits, Personal Protection Equipment (PPE) and Medical Supplies
March 23, 2020 07:00 ET | Parallax Health Sciences, Inc.
Company Benefits from Unique Chinese, Hong Kong, Macau Diagnostic Patent Rights, and Closes Deal to Help America Now NEW YORK, NY, March 23, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax...
OptimizeRx Secures Two Additional Enterprise Clients on Newly Integrated Digital Healthcare Platform
March 11, 2020 08:31 ET | OptimizeRx Corporation
ROCHESTER, Mich., March 11, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, has secured two additional...
PTS Diagnostics Anno
PTS Diagnostics Announces New Retail Point-of-Care Software
January 04, 2018 08:15 ET | PTS Diagnostics
 PTS Connect ProLink® platform expands connectivity and informatics offerings INDIANAPOLIS, Jan. 04, 2018 (GLOBE NEWSWIRE) -- PTS Diagnostics, a U.S.-based manufacturer of point-of-care biometric...